Johns Hopkins ABX Guide
Technivie
Technivie is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Technivie: combination pack of three medications, ombitasvir/paritaprevir/ritonavir. Indicated for the treatment of chronic hepatitis C virus (HCV) genotype 4 infection without cirrhosis with or without the addition of ribavirin.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: January 6, 2016
Citation
Dzintars, Kathryn. "Technivie." Johns Hopkins ABX Guide, The Johns Hopkins University, 2016. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/5/Technivie.
Dzintars K. Technivie. Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/5/Technivie. Accessed November 20, 2019.
Dzintars, K. (2016). Technivie. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/5/Technivie
Dzintars K. Technivie [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. [cited 2019 November 20]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/5/Technivie.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Technivie
ID - 540655
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2016/01/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/5/Technivie
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -